Pfizer Expert Meeting: Antikoagulant Academy
The Pfizer Expert Meeting: Antikoagulant Academy will address key challenges in the use of non-vitamin K antagonist oral anticoagulants (NOACs) for patients with atrial fibrillation (AF). The program includes a critical discussion on whether clinical guidelines and practices for NOAC use in complex AF patients have evolved or remained consistent.
Participants will gain valuable insights through case presentations that explore real-world scenarios. Topics include managing AF in patients with a high bleeding risk, addressing AF in individuals with reduced renal function, and tailoring treatment strategies for elderly patients with high-risk profiles.
This meeting serves as an essential platform for sharing knowledge, fostering collaboration, and refining approaches to anticoagulant therapy, ensuring optimal care for diverse and challenging patient populations. Experts and practitioners are encouraged to join the conversation and contribute to advancing clinical excellence.